Author:
Warkad Shrikant,Nimse Satish,Song Keum-Soo,Kim Taisun
Abstract
According to the World Health Organization (WHO), 71 million people were living with Hepatitis C virus (HCV) infection worldwide in 2015. Each year, about 399,000 HCV-infected people succumb to cirrhosis, hepatocellular carcinoma, and liver failure. Therefore, screening of HCV infection with simple, rapid, but highly sensitive and specific methods can help to curb the global burden on HCV healthcare. Apart from the determination of viral load/viral clearance, the identification of specific HCV genotype is also critical for successful treatment of hepatitis C. This critical review focuses on the technologies used for the detection, discrimination, and genotyping of HCV in clinical samples. This article also focuses on advantages and disadvantages of the reported methods used for HCV detection, quantification, and genotyping.
Subject
Electrical and Electronic Engineering,Biochemistry,Instrumentation,Atomic and Molecular Physics, and Optics,Analytical Chemistry
Reference131 articles.
1. Introduction: A smouldering public-health crisis
2. Global Hepatitis Reporthttps://afro.who.int/sites/default/files/2017-06/9789241565455-eng.pdf
3. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
4. Epidemiology and natural history of hepatitis C virus Infection;Lee;World J. Gastroenterol.,2014
5. Guidelines for the Care and Treatment of Persons Diagnosed with Chronic Hepatitis C Virus Infectionhttp://apps.who.int/iris/bitstream/handle/10665/273174/9789241550345-eng.pdf?ua=1
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献